{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:52:23Z","timestamp":1794941543572,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteoporosis is a systemic, multifactorial disorder of bone mineralization. Many factors contributing to the development of osteoporosis have been identified so far, including gender, age, nutrition, lifestyle, exercise, drug use, as well as a range of comorbidities. In addition to environmental and lifestyle factors, molecular genetic factors account for 50\u201385% of osteoporosis cases. For example, the vitamin D receptor (VDR), collagen type I (COL1), estrogen receptor (ER), apolypoprotein \u0415 (ApoE), bone morphogenetic protein (BMP), and Low-density lipoprotein receptor-related protein 5 (LRP5) are all involved in the pathogenesis of osteoporosis. Among the candidate genes, the pathogenic variants in which are involved in the pathogenesis of osteoporosis is <jats:italic>FGFR2<\/jats:italic>. Additionally, FGFs\/FGFRs-dependent signaling has been shown to regulate skeletal development and has been linked to a plethora of heritable disorders of the musculoskeletal system. In this study we present the clinical, biochemical and radiological findings, as well as results of molecular genetic testing of a 13-year-old male proband with heritable osteoporosis, arthralgia and multiple fractures and a family history of abnormal bone mineralization and fractures. Whole exome sequencing found a heterozygous previously undescribed variant in the <jats:italic>FGFR2<\/jats:italic> gene (NM_000141.5) (GRCh37.p13 ENSG00000066468.16: g.123298133dup; ENST00000358487.5:c.722dup; ENSP00000351276.5:p.Asn241LysfsTer43). The same variant was found in two affected relatives. These data lead us to believe that the variant in <jats:italic>FGFR2<\/jats:italic> found in our proband and his relatives could be related to their phenotype. Therefore, modern methods of molecular genetic testing can allow us to differentiate between osteogenesis imperfecta and other bone mineralization disorders.<\/jats:p>","DOI":"10.1186\/s12920-023-01750-1","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T14:02:54Z","timestamp":1702562574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An FGFR2 mutation as the potential cause of a new phenotype including early-onset osteoporosis and bone fractures: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Ilya S","family":"Dantsev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia A","family":"Parfenenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnara M","family":"Radzhabova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina A","family":"Nikolaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"1750_CR1","first-page":"336","volume":"87","author":"DZ Dodd","year":"2013","unstructured":"Dodd DZ, Rowe DJ. The relationship between postmenopausal osteoporosis and periodontal Disease. J Dent Hyg. 2013;87:336\u201344.","journal-title":"J Dent Hyg"},{"key":"1750_CR2","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00198-011-1754-3","volume":"23","author":"R El Hage","year":"2012","unstructured":"El Hage R. Geometric indices of hip bone strength in obese, overweight, and normal-weight adolescent boys. Osteoporos Int. 2012;23:1593\u2013600. https:\/\/doi.org\/10.1007\/s00198-011-1754-3.","journal-title":"Osteoporos Int"},{"key":"1750_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L, et al. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16:609. https:\/\/doi.org\/10.1186\/s13018-021-02772-0.","journal-title":"J Orthop Surg Res"},{"key":"1750_CR4","doi-asserted-by":"publisher","first-page":"e0174808","DOI":"10.1371\/journal.pone.0174808","volume":"12","author":"K Liu","year":"2017","unstructured":"Liu K, Tan LJ, Wang P, Chen XD, Zhu LH, Zeng Q, et al. Functional relevance for associations between osteoporosis and genetic variants. PLoS ONE. 2017;12:e0174808. https:\/\/doi.org\/10.1371\/journal.pone.0174808.","journal-title":"PLoS ONE"},{"key":"1750_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mce.2015.12.021","volume":"432","author":"E Boudin","year":"2016","unstructured":"Boudin E, Fijalkowski I, Hendrickx G, Van Hul W. Genetic control of bone mass. Mol Cell Endocrinol. 2016;432:3\u201313. https:\/\/doi.org\/10.1016\/j.mce.2015.12.021.","journal-title":"Mol Cell Endocrinol"},{"key":"1750_CR6","doi-asserted-by":"publisher","unstructured":"Liu G, Xiong D, Xiao R, Huang Z. Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: a systematic review and meta-analysis. Tumour Biol. 2017;39. https:\/\/doi.org\/10.1177\/1010428317707424.","DOI":"10.1177\/1010428317707424"},{"key":"1750_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1247\/csf.25.85","volume":"25","author":"I McIntosh","year":"2000","unstructured":"McIntosh I, Bellus GA, Jab EW. The pleiotropic effects of fibroblast growth factor receptors in mammalian development. Cell Struct Funct. 2000;25:85\u201396. https:\/\/doi.org\/10.1247\/csf.25.85.","journal-title":"Cell Struct Funct"},{"key":"1750_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ydbio.2006.10.014","volume":"302","author":"JS Lunn","year":"2007","unstructured":"Lunn JS, Fishwick KJ, Halley PA, Storey KG. A spatial and temporal map of FGF\/Erk1\/2 activity and response repertoires in the early chick embryo. Dev Biol. 2007;302:536\u201352. https:\/\/doi.org\/10.1016\/j.ydbio.2006.10.014.","journal-title":"Dev Biol"},{"key":"1750_CR9","doi-asserted-by":"publisher","unstructured":"Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P. (2004) A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 12555\u201312560, https:\/\/doi.org\/10.1073\/pnas.0405031101.","DOI":"10.1073\/pnas.0405031101"},{"key":"1750_CR10","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1083\/jcb.149.6.1297","volume":"149","author":"A Mansukhani","year":"2000","unstructured":"Mansukhani A, Bellosta P, Sahni M, Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol. 2000;149:1297\u2013308. https:\/\/doi.org\/10.1083\/jcb.149.6.1297.","journal-title":"J Cell Biol"},{"key":"1750_CR11","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1242\/dev.131722","volume":"143","author":"K Karuppaiah","year":"2016","unstructured":"Karuppaiah K, Yu K, Lim J, Chen J, Smith C, Long F, et al. FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth. Development. 2016;143:1811\u201322. https:\/\/doi.org\/10.1242\/dev.131722.","journal-title":"Development"},{"key":"1750_CR12","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190275","author":"Yang Yang1, Mengxue Fei","year":"2019","unstructured":"Yang Yang1, Mengxue Fei. The association of genetic variants in FGFR2 with osteoporosis susceptibility in Chinese Han population. Biosci Rep. 2019. https:\/\/doi.org\/10.1042\/BSR20190275.","journal-title":"Biosci Rep"},{"issue":"11","key":"1750_CR13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Pesaran T, DiStefano MT, et al. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum Mutat. 2018;39(11):1517\u201324. https:\/\/doi.org\/10.1002\/humu.23626.","journal-title":"Hum Mutat"},{"key":"1750_CR14","doi-asserted-by":"publisher","unstructured":"Rieux-Laucat F, Casanova JL. Immunology. Autoimmunity by haploinsufficiency. Volume 345. Science (New York; 2014. pp. 1560\u20131. 6204https:\/\/doi.org\/10.1126\/science.1260791.","DOI":"10.1126\/science.1260791"},{"issue":"8","key":"1750_CR15","doi-asserted-by":"publisher","first-page":"e1001935","DOI":"10.1371\/journal.pbio.1001935","volume":"12","author":"B Szamecz","year":"2014","unstructured":"Szamecz B, Boross G, Kalapis D, Kov\u00e1cs K, Fekete G, Farkas Z, L\u00e1z\u00e1r V, Hrtyan M, Kemmeren P, Groot Koerkamp MJ, Rutkai E, Holstege FC, Papp B, P\u00e1l C. The genomic landscape of compensatory evolution. PLoS Biol. 2014;12(8):e1001935. https:\/\/doi.org\/10.1371\/journal.pbio.1001935.","journal-title":"PLoS Biol"},{"issue":"7","key":"1750_CR16","doi-asserted-by":"publisher","first-page":"e1003757","DOI":"10.1371\/journal.pcbi.1003757","volume":"10","author":"A Rausell","year":"2014","unstructured":"Rausell A, Mohammadi P, McLaren PJ, Bartha I, Xenarios I, Fellay J, Telenti A. Analysis of stop-gain and frameshift variants in human innate immunity genes. PLoS Comput Biol. 2014;10(7):e1003757. https:\/\/doi.org\/10.1371\/journal.pcbi.1003757.","journal-title":"PLoS Comput Biol"},{"key":"1750_CR17","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1148\/rg.2017170017","volume":"37","author":"KM Sargar","year":"2017","unstructured":"Sargar KM, Singh AK, Kao SC. Imaging of skeletal disorders caused by fibroblast growth factor receptor gene mutations. Radiographics. 2017;37:1813\u201330. https:\/\/doi.org\/10.1148\/rg.2017170017.","journal-title":"Radiographics"},{"key":"1750_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ajhg.2012.02.005","volume":"90","author":"AE Merrill","year":"2012","unstructured":"Merrill AE, et al. Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling. Am J Hum Genet. 2012;90:550\u20137. https:\/\/doi.org\/10.1016\/j.ajhg.2012.02.005.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1750_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s11914-019-00512-2","volume":"17","author":"CT Tuzon","year":"2019","unstructured":"Tuzon CT, Rigueur D, Merrill AE. Nuclear fibroblast growth factor receptor signaling in skeletal development and Disease. Curr Osteoporos Rep. 2019;17(3):138\u201346. https:\/\/doi.org\/10.1007\/s11914-019-00512-2.","journal-title":"Curr Osteoporos Rep"},{"key":"1750_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1210\/me.2013-1305","volume":"28","author":"Y Soung do","year":"2014","unstructured":"Soung do Y, Kalinowski J, Baniwal SK, Jacome-Galarza CE, Frenkel B, Lorenzo J, et al. Runx1-mediated regulation of osteoclast differentiation and function. Mol Endocrinol. 2014;28:546\u201353. https:\/\/doi.org\/10.1210\/me.2013-1305.","journal-title":"Mol Endocrinol"},{"key":"1750_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","volume":"89","author":"V Shalhoub","year":"2011","unstructured":"Shalhoub V, Ward SC, Sun B, Stevens J, Renshaw L, Hawkins N, et al. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcif Tissue Int. 2011;89:140\u201350. https:\/\/doi.org\/10.1007\/s00223-011-9501-5.","journal-title":"Calcif Tissue Int"},{"key":"1750_CR22","doi-asserted-by":"publisher","unstructured":"Wei W, Dutchak PA, Wang X, Ding X, Bookout AL, Goetz R et al. (2012) Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma. Proc. Natl. Acad. Sci. U.S.A. 109, 3143\u20133148, https:\/\/doi.org\/10.1073\/pnas.1200797109.","DOI":"10.1073\/pnas.1200797109"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01750-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T14:06:38Z","timestamp":1702562798000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01750-1","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the proband\u2019s parents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"329"}}